154 related articles for article (PubMed ID: 33088693)
1. A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy.
Hou X; Shou C; He M; Xu J; Cheng Y; Yuan Z; Lan M; Zhao Y; Yang Y; Chen X; Gao F
Acta Pharm Sin B; 2020 Sep; 10(9):1741-1753. PubMed ID: 33088693
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporally controllable diphtheria toxin expression using a light-switchable transgene system combining multifunctional nanoparticle delivery system for targeted melanoma therapy.
He M; Wang Y; Chen X; Zhao Y; Lou K; Wang Y; Huang L; Hou X; Xu J; Cai X; Cheng Y; Lan M; Yang Y; Gao F
J Control Release; 2020 Mar; 319():1-14. PubMed ID: 31838205
[TBL] [Abstract][Full Text] [Related]
3. Light-switchable diphtherin transgene system combined with losartan for triple negtative breast cancer therapy based on nano drug delivery system.
Cheng Y; Sun R; He M; Zhang M; Hou X; Sun Y; Wang J; Xu J; He H; Wang H; Lan M; Zhao Y; Yang Y; Chen X; Gao F
Int J Pharm; 2022 Apr; 618():121613. PubMed ID: 35217071
[TBL] [Abstract][Full Text] [Related]
4. Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy.
Cheng Y; Zou J; He M; Hou X; Wang H; Xu J; Yuan Z; Lan M; Yang Y; Chen X; Gao F
J Control Release; 2024 Mar; 367():167-183. PubMed ID: 37562556
[TBL] [Abstract][Full Text] [Related]
5. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition.
Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626
[TBL] [Abstract][Full Text] [Related]
6. Fine tuning the LightOn light-switchable transgene expression system.
Ma Z; Du Z; Chen X; Wang X; Yang Y
Biochem Biophys Res Commun; 2013 Oct; 440(3):419-23. PubMed ID: 24095689
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy.
He M; Sun Y; Cheng Y; Wang J; Zhang M; Sun R; Hou X; Xu J; He H; Wang H; Yuan Z; Lan M; Zhao Y; Yang Y; Chen X; Gao F
J Control Release; 2023 Mar; 355():538-551. PubMed ID: 36063962
[TBL] [Abstract][Full Text] [Related]
8. Safe and Efficacious Diphtheria Toxin-Based Treatment for Melanoma: Combination of a Light-On Gene-Expression System and Nanotechnology.
Xu J; He M; Hou X; Wang Y; Shou C; Cai X; Yuan Z; Yin Y; Lan M; Lou K; Zhao Y; Yang Y; Chen X; Gao F
Mol Pharm; 2020 Jan; 17(1):301-315. PubMed ID: 31765570
[TBL] [Abstract][Full Text] [Related]
9. Spatiotemporal control of gene expression in mammalian cells and in mice using the LightOn system.
Chen X; Wang X; Du Z; Ma Z; Yang Y
Curr Protoc Chem Biol; 2013; 5(2):111-29. PubMed ID: 23839993
[TBL] [Abstract][Full Text] [Related]
10. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
11. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
12. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
Gu J; Chen X; Fang X; Sha X
Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
14. Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System.
Yu T; Li Y; Gu X; Li Q
Front Pharmacol; 2020; 11():532457. PubMed ID: 32982750
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
16. Increasing cancer-specific gene expression by targeting overexpressed α5β1 integrin and upregulated transcriptional activity of NF-κB.
Adil MM; Levine RM; Kokkoli E
Mol Pharm; 2014 Mar; 11(3):849-58. PubMed ID: 24483950
[TBL] [Abstract][Full Text] [Related]
17. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
18. Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.
Fan B; Kang L; Chen L; Sun P; Jin M; Wang Q; Bae YH; Huang W; Gao Z
Theranostics; 2017; 7(2):357-376. PubMed ID: 28042340
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis.
Huang S; Shao K; Liu Y; Kuang Y; Li J; An S; Guo Y; Ma H; Jiang C
ACS Nano; 2013 Mar; 7(3):2860-71. PubMed ID: 23451830
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis.
Doolittle E; Peiris PM; Doron G; Goldberg A; Tucci S; Rao S; Shah S; Sylvestre M; Govender P; Turan O; Lee Z; Schiemann WP; Karathanasis E
ACS Nano; 2015 Aug; 9(8):8012-21. PubMed ID: 26203676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
